Home › All Companies › CNC › Annual Report

CENTENE CORP (CNC) — Annual Report

AI-Powered SEC Filing Analysis

← All CNC filings
Latest Annual Report Filed: 2026-02-17

Key Insights

  • Centene's revenue from healthcare premiums and services grew steadily over the past 3 years, indicating strong business performance.
  • The company has made strategic divestitures of Magellan Rx and Magellan Specialty Health, potentially streamlining operations and improving profitability.
  • Centene's Medicare Advantage membership is projected to grow, which could drive higher revenue in the Medicare segment.
Sentiment: Positive Significance: 6/10
View Original Filing →

Want the newest filings?

This analysis covers the filing from 2026-02-17. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Other reports for CENTENE CORP

Current Report Quarterly Report Insider Trading

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.